Curcumin, novel application in reversing myocardial fibrosis in the treatment for atrial fibrillation from the perspective of transcriptomics in rat model
Authors:
Open Access
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 146, 112522
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82172060)
- Sichuan University
- West China Hospital, Sichuan University (2020HXBH106)
This publication has 44 references indexed in Scilit:
- Curcuminoids for the management of hypertriglyceridaemiaNature Reviews Cardiology, 2014
- Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult PopulationThe American Journal of Cardiology, 2013
- Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1Cellular Signalling, 2012
- Molecular mechanisms for curcumin benefits against ischemic injuryFertility and Sterility, 2010
- Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in diseaseImmunology, 2010
- DEGseq: an R package for identifying differentially expressed genes from RNA-seq dataBioinformatics, 2009
- Extracellular Matrix Alterations in Patients With Paroxysmal and Persistent Atrial FibrillationJACC, 2008
- Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical TrialsAntioxidants & Redox Signaling, 2008
- Downregulation of VEGF‐D expression by interleukin‐1β in cardiac microvascular endothelial cells is mediated by MAPKs and PKCα/β1Journal of Cellular Physiology, 2007
- Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosisCancer Genetics and Cytogenetics, 2007